Abio-X

3 biotech executives on the year ahead: deals, drug pricing and the down market
BioPharma Dive
Thu, 01/19/23 - 07:46 pm
JPMHC 2023
LifeMine
Ovid Therapeutics
Abio-X
Pharma CEOs
Biotech veteran Jeff Jonas on leaving Sage, guiding new biotechs and his ‘personal odyssey’
BioPharma Dive
Wed, 12/7/22 - 09:47 am
SAGE Therapeutics
Jeff Jonas
Pharma CEOs
biotech
Abio-X
incubators